Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
8.40
+0.90 (12.00%)
At close: Sep 4, 2026, 4:00 PM EDT
8.45
+0.05 (0.60%)
After-hours: Sep 4, 2026, 7:33 PM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $554.49 million as of September 4, 2026. Its market cap has increased by 183.46% in one year.
Market Cap
554.49M
Enterprise Value
447.85M
1-Year Change
183.46%
Ranking
Category
Stock Price
$8.40
ChartMarket Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $554.49M, an increase of 799.88%. That is a compound annual growth rate of 49.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 554.49M | 45.45% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 596.20M |
| REGENXBIO | 590.16M |
| Cabaletta Bio | 588.32M |
| Eikon Therapeutics | 588.23M |
| Prelude Therapeutics | 562.35M |
| ARS Pharmaceuticals | 558.89M |
| Artiva Biotherapeutics | 547.08M |
| Ovid Therapeutics | 546.83M |